Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Protocols / BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

Morre, D. JamesNOX Technologies
Breast and Gynecologic Cancers Research

Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our derivation

To obtain preliminary indications of utility for serum detection of breast and ovarian cancer.
sandwich ELISA

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.